3 results
The primary aim of this pilot-study is to assess safety and the effects on immune function in patients with septic shock of adjunctive therapy with IFN-gamma, in a placebo-controlled manner. The data obtained will allow us to do a powercalculation…
The current trial aims to demonstrate that sugammadex is generally safe and effective for reversing both moderate and deep block after rocuronium or vecuronium induced NMB in term neonates and young children.
This explorative feasibility study will focus on developing a treatment protocol for light therapy in older adults with dementia and a depressive disorder. However, it is important to first consider whether the treatment is feasible at this target…